25.4 C
New York
Saturday, June 13, 2026

Tag: management team

newssourceFORcompanyinformationcontent1marketreleases

Argenta Silver Announces Closing of Additional Investment of C$2.5 Million

TSX-V:AGAG VANCOUVER, BC, Aug. 12, 2025 /CNW/ - Argenta Silver Corp. (TSXV: AGAG) (FSE: T1K) ("Argenta" or the "Company") is pleased to announce the closing of...

Caris Life Sciences Reports Second Quarter 2025 Financial Results

IRVING, Texas, Aug. 12, 2025 /PRNewswire/ -- Caris Life Sciences, Inc. (Nasdaq: CAI), a leading, patient-centric, next-generation AI TechBio company, today reported financial results...

Argenta Silver Announces Closing of Bought Deal Private Placement for Gross Proceeds of C$15 Million

/THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/              ...

izmo Ltd. unveils The Automotive AI Factory

Powering the Future of Intelligent Automotive Solutions BANGALORE, India, Aug. 12, 2025 /PRNewswire/ -- izmo Ltd., a global leader in automotive digital retail solutions, today announced...

Oculis to Participate in Upcoming H.C Wainwright 5th Annual Ophthalmology Virtual Conference

ZUG, Switzerland, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS; XICE: OCS) (“Oculis”), a global biopharmaceutical company focused on innovations addressing ophthalmic and neuro-ophthalmic conditions with significant unmet medical needs, today announced that Oculis’ management will be participating in the H.C Wainwright 5th Annual Ophthalmology Virtual Conference on August 13, 2025.

Elliott Statement on Sumitomo Realty & Development Co., Ltd.

LONDON, Aug. 12, 2025 /PRNewswire/ -- Elliott Investment Management, L.P. and Elliott Advisors (UK) Limited ("Elliott"), which advise funds that together have a more...

Fosun Pharma’s Small Molecule Innovative Drug XH-S004 Achieves Overseas Licensing for a Potential Total of $645 Million

SHANGHAI, Aug. 11, 2025 /PRNewswire/ -- On August 11, Fosun Pharma (SSE:600196, HKEX: 02196) announced that its subsidiary Fosun Pharma Industrial has signed a License...

NGEx Reports Q2 2025 Results; Porphyry and High-grade Gold Discoveries at Lunahuasi; Plan to Spin-out Royalties to Shareholders

VANCOUVER, BC, Aug. 11, 2025 /CNW/ - NGEx Minerals Ltd. ("NGEx Minerals" "NGEx" or the "Company") (TSX: NGEX) (OTCQX: NGXXF) is pleased to report...

Quipt Home Medical Reports Improved Fiscal Third Quarter 2025 Results

Posts Positive Organic Growth and Adjusted EBITDA‎1 of 23.5% of Revenue

HF Foods Reports Second Quarter 2025 Financial Results

Reports Quarterly Record Net Revenue and Gross Profit 
Reports Quarterly Record Net Revenue and Gross Profit

VIZSLA SILVER ANNOUNCES CHANGE OF TRANSFER AGENT

NYSE: VZLA     TSX: VZLA VANCOUVER, BC, Aug. 11, 2025 /PRNewswire/ - Vizsla Silver Corp. (TSX: VZLA) (NYSE: VZLA) (Frankfurt: 0G3) ("Vizsla Silver" or the "Company")...

VIZSLA SILVER ANNOUNCES CHANGE OF TRANSFER AGENT

NYSE: VZLA     TSX: VZLA VANCOUVER, BC, Aug. 11, 2025 /CNW/ - Vizsla Silver Corp. (TSX: VZLA) (NYSE: VZLA) (Frankfurt: 0G3) ("Vizsla Silver" or the "Company")...

Everest Medicines to Announce 2025 Interim Results on August 29, 2025

SHANGHAI, Aug. 11, 2025 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing and...

Everest Medicines to Announce 2025 Interim Results on August 29, 2025

SHANGHAI, Aug. 11, 2025 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing and...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsManagement team

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers